Next-generation sequencing (NGS) in pancreatic neuroendocrine tumors (panNETs): Defining differentiation and grade genetically.
Raj N, Klimstra D, Shah R, Osoba M, Alexander D, Reidy D. Next-generation sequencing (NGS) in pancreatic neuroendocrine tumors (panNETs): Defining differentiation and grade genetically. Journal Of Clinical Oncology 2017, 35: 291-291. DOI: 10.1200/jco.2017.35.4_suppl.291.Peer-Reviewed Original ResearchChromatin remodeling genesNext-generation sequencingWD tumorsPD tumorsRemodeling genesMSK-IMPACTCopy number changesDetect base substitutionsPancreatic neuroendocrine tumorsWhole-exome sequencingCancer related genesSmall indelsSequencing technologiesBase substitutionsExon coverageTP53 alterationsNeuroendocrine carcinomaExome sequencingNeuroendocrine tumorsRB1 alterationsGenetic basisATRX alterationsTumor differentiationProspective studyChromatin
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply